Potential Clindamycin Resistance in Clindamycin-Susceptible, Erythromycin-Resistant Staphylococcus aureus: Report of a Clinical Failure

AUTOR(ES)

Levin, Todd P.

FONTE

American Society for Microbiology

RESUMO

The erm gene product confers clindamycin resistance on Staphylococcus aureus. We report a clindamycin clinical failure where resistance developed on therapy in a D-test-positive strain. D tests of 91 clindamycin-susceptible, erythromycin-resistant S. aureus isolates showed that 68% of methicillin-susceptible and 12.3% of methicillin-resistant S. aureus strains were D-test positive.

Documentos Relacionados

• Emergence of Erythromycin-Resistant, Clindamycin-Susceptible Streptococcus pyogenes Isolates in Madrid, Spain
• Altered Methylation of Ribosomal RNA in an Erythromycin-Resistant Strain of Staphylococcus aureus
• Differentiation of Resistance Phenotypes among Erythromycin-Resistant Pneumococci
• Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988.
• Erythromycin-resistant Campylobacter infections in Thailand.